A new gene therapy is giving people born deaf the chance to hear, often within just weeks. In a small but groundbreaking ...

A groundbreaking gene therapy trial has successfully restored hearing in individuals with a rare form of congenital deafness.

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTC: FCSC) today announced that its Phase 2 study to evaluate the safety and efficacy of azficel-T (LAVIV®) for the treatment of patients with ...

Russell has a PhD in the history of medicine, violence, and colonialism. His research has explored topics including ethics, science governance, and medical involvement in violent contexts. Russell has ...

Scientists have designed a new type of oral capsule that could mean pain-free delivery of insulin and other protein drugs. Protein drugs had proven challenging to deliver orally as the drugs degrade ...

MIT engineers have devised a new way to deliver certain drugs in higher doses with less pain, by injecting them as a suspension of tiny crystals. Once under the skin, the crystals assemble into a drug ...